X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (26625) 26625
Book Chapter (87) 87
Dissertation (39) 39
Conference Proceeding (28) 28
Publication (26) 26
Magazine Article (23) 23
Web Resource (10) 10
Book / eBook (4) 4
Newspaper Article (4) 4
Trade Publication Article (3) 3
Newsletter (2) 2
Paper (2) 2
Reference (2) 2
Book Review (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bevacizumab (22467) 22467
humans (17481) 17481
female (10307) 10307
oncology (9185) 9185
male (8779) 8779
middle aged (7413) 7413
aged (6986) 6986
ophthalmology (6480) 6480
chemotherapy (5574) 5574
cancer (5011) 5011
angiogenesis inhibitors - therapeutic use (4909) 4909
adult (4898) 4898
treatment outcome (4694) 4694
vascular endothelial growth factor (4349) 4349
endothelial growth-factor (4308) 4308
antibodies, monoclonal, humanized (4172) 4172
vascular endothelial growth factor a - antagonists & inhibitors (4076) 4076
angiogenesis (3830) 3830
antineoplastic combined chemotherapy protocols - therapeutic use (3650) 3650
ranibizumab (3267) 3267
aged, 80 and over (3154) 3154
therapy (3064) 3064
care and treatment (3045) 3045
angiogenesis inhibitors - administration & dosage (3013) 3013
retrospective studies (2795) 2795
animals (2691) 2691
intravitreal injections (2684) 2684
metastasis (2521) 2521
antibodies, monoclonal - therapeutic use (2463) 2463
survival (2443) 2443
macular degeneration (2414) 2414
colorectal cancer (2361) 2361
vegf (2152) 2152
antibodies, monoclonal - administration & dosage (2107) 2107
medicine & public health (2088) 2088
antibodies, monoclonal, humanized - administration & dosage (2056) 2056
antibodies, monoclonal, humanized - therapeutic use (2025) 2025
research (2003) 2003
surgery (1991) 1991
trial (1953) 1953
follow-up studies (1920) 1920
colorectal neoplasms - drug therapy (1917) 1917
patients (1909) 1909
antineoplastic agents - therapeutic use (1902) 1902
prognosis (1899) 1899
pharmacology & pharmacy (1845) 1845
tumors (1840) 1840
eye diseases (1821) 1821
tomography, optical coherence (1789) 1789
disease-free survival (1771) 1771
analysis (1755) 1755
drug therapy (1755) 1755
angiogenesis inhibitors - adverse effects (1673) 1673
angiogenesis inhibitors (1672) 1672
clinical trials (1632) 1632
expression (1612) 1612
fluorescein angiography (1573) 1573
intravitreal bevacizumab (1570) 1570
combination (1535) 1535
colorectal neoplasms - pathology (1522) 1522
genetic structures (1520) 1520
bevacizumab - administration & dosage (1473) 1473
visual acuity (1446) 1446
fluorouracil (1436) 1436
prospective studies (1430) 1430
oxaliplatin (1424) 1424
bevacizumab - therapeutic use (1420) 1420
paclitaxel (1358) 1358
cetuximab (1355) 1355
antineoplastic combined chemotherapy protocols - adverse effects (1346) 1346
1st-line treatment (1333) 1333
antineoplastic agents (1303) 1303
cancer therapies (1303) 1303
mice (1282) 1282
efficacy (1269) 1269
neovascularization (1262) 1262
health aspects (1258) 1258
irinotecan (1246) 1246
lung neoplasms - drug therapy (1242) 1242
visual acuity - physiology (1222) 1222
antimitotic agents (1218) 1218
injection (1214) 1214
avastin (1213) 1213
leucovorin (1210) 1210
hematology, oncology and palliative medicine (1208) 1208
sense organs (1204) 1204
glioblastoma (1195) 1195
diabetic retinopathy (1180) 1180
phase-ii trial (1176) 1176
neoplasm staging (1164) 1164
neoplasm metastasis (1147) 1147
abridged index medicus (1123) 1123
antibodies, monoclonal - adverse effects (1121) 1121
phase-ii (1105) 1105
open-label (1070) 1070
vascular endothelial growth factor a - metabolism (1069) 1069
risk factors (1064) 1064
combined modality therapy (1063) 1063
breast cancer (1059) 1059
studies (1045) 1045
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (24795) 24795
German (605) 605
French (579) 579
Japanese (449) 449
Spanish (206) 206
Chinese (174) 174
Korean (170) 170
Portuguese (102) 102
Russian (76) 76
Turkish (60) 60
Czech (51) 51
Polish (50) 50
Hungarian (37) 37
Italian (22) 22
Romanian (13) 13
Norwegian (11) 11
Dutch (9) 9
Slovenian (8) 8
Finnish (5) 5
Slovak (4) 4
Swedish (4) 4
Danish (3) 3
Croatian (2) 2
Hebrew (2) 2
Arabic (1) 1
Bosnian (1) 1
Icelandic (1) 1
Indonesian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 20, pp. 1954 - 1963
The addition of bevacizumab to lomustine in patients with recurrent glioblastoma failed to increase overall survival but was associated with a small increase... 
Medicine(all) | MEDICINE, GENERAL & INTERNAL | METHYLATION | PROGNOSTIC-FACTORS | PLUS IRINOTECAN | SINGLE-AGENT BEVACIZUMAB | RESPONSE ASSESSMENT | CLINICAL-TRIALS | PHASE-2 | QUALITY-OF-LIFE | RADIOTHERAPY | TEMOZOLOMIDE | Bevacizumab - administration & dosage | Bevacizumab - adverse effects | Humans | Lomustine - adverse effects | Middle Aged | Kaplan-Meier Estimate | Male | Antineoplastic Agents, Alkylating - administration & dosage | Brain Neoplasms - drug therapy | Chemoradiotherapy | Glioblastoma - radiotherapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Aged, 80 and over | Adult | Female | Aged | Brain Neoplasms - mortality | Antineoplastic Agents, Alkylating - adverse effects | Brain Neoplasms - radiotherapy | Glioblastoma - drug therapy | Glioblastoma - mortality | Lomustine - administration & dosage | Patient outcomes | Lomustine | Outcome and process assessment (Health Care) | Dosage and administration | Research | Drug therapy | Glioblastoma multiforme | Methods | Medical research | Nuclear magnetic resonance--NMR | Brain cancer | Methylguanine | Glioblastoma | Clinical trials | Oncology | Cognition | Cancer therapies | Survival | Quality of life | Bevacizumab | O6-methylguanine-DNA methyltransferase | Studies | Brain research | DNA methylation | DNA methyltransferase | Cancer | Life Sciences
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 77, pp. 13 - 20
Journal Article
Journal of biomedical materials research. Part A, ISSN 1549-3296, 2015, Volume 103, Issue 10, pp. 3148 - 3156
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10026, pp. 1405 - 1414
Journal Article
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1306 - 1315
Summary Background In the TRIBE study, FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus bevacizumab significantly improved... 
Hematology, Oncology and Palliative Medicine | TRIAL | CETUXIMAB | SURROGATE | LEUCOVORIN | ONCOLOGY | END-POINT | PROGRESSION-FREE SURVIVAL | RAS MUTATIONS | GUIDELINES | KRAS | FLUOROURACIL | Leucovorin - administration & dosage | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Bevacizumab - therapeutic use | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Angiogenesis Inhibitors - therapeutic use | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Bevacizumab - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Intention to Treat Analysis | Italy | Aged | Infusions, Intravenous | Mutation | Colorectal Neoplasms - pathology | Antimitotic agents | Cancer patients | Care and treatment | Patient outcomes | Analysis | Colorectal cancer | Leucovorin | Metastasis | Antineoplastic agents
Journal Article
Survey of ophthalmology, ISSN 0039-6257, 2015, Volume 60, Issue 6, pp. 524 - 535
Journal Article
Journal of neurosurgery, ISSN 1933-0693, 2016, Volume 124, Issue 4, pp. 998 - 1007
Journal Article
Ophthalmology, ISSN 0161-6420, 2016, Volume 124, Issue 3, pp. 408 - 409
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 779 - 791
Journal Article